Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03670030
Title A Study to Test the Effectiveness of ABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Robert Ramirez
Indications

gastrointestinal neuroendocrine tumor

pulmonary neuroendocrine tumor

pancreatic endocrine carcinoma

Therapies

Nab-rapamycin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.